FDAnews Device Daily Bulletin

FDA OKs Three Boston Scientific Products

Feb. 26, 2008

Boston Scientific has received FDA approval for the Confient implantable cardioverter defibrillator (ICD), the Livian cardiac resynchronization therapy defibrillator (CRT-D) and an upgraded Latitude patient management system.

The Confient ICD helps protect patients at risk of sudden death, and the Livian CRT-D provides cardiac resynchronization and defibrillation.

Both devices enable physicians to manage their patients wirelessly on the Latitude system, which notifies physicians of changes in a patient’s status between scheduled follow-ups, Boston Scientific said.